Acurx target adjusted to $31 from $8 at H.C. Wainwright

H.C. Wainwright adjusted the firm’s price target on Acurx (ACXP) to $31 from $8 and keeps a Buy rating on the shares following the recent 1-for-20 reverse stock split. The firm believes the company’s lead asset ibezapolstat is making steady progress as it prepares to enter Phase 3 evaluation.